The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Attrogy (diflunisal) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

The post Purpose Pharma receives positive CHMP opinion appeared first on NLS.

The acceleration program is organized by the Swedish-American Chamber of Commerce in New York (SACCNY) in collaboration with EY.

The post Neogap Therapeutics selected for Innovate Nordics 2025 Acceleration Program appeared first on NLS.

The new award, Pioneer Prize, launched by the Swedish Institute and Business Sweden, aims to highlight the best in Swedish innovation.

The post Neola Medical nominated for the Pioneer Prize appeared first on NLS.

Diamyd Medical's patent application protecting the use of insulin-based antigens for the treatment of autoimmune diabetes in patients carrying the HLA DR4-DQ8 genetic marker will be granted by the European Patent Office (EPO).

The post Diamyd Medical granted European patent appeared first on NLS.

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for market authorization of Oczyesa, octreotide subcutaneous depot, for the maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.

The post CHMP recommends approval of Camurus’ Oczyesa appeared first on NLS.

Cellevate, Fraunhofer IBMT (Institute for Biomedical Engineering), and the German bioreactor company OLS (Omni Life Science) have been awarded a EUR 1 million grant through the Eurostar program for large scale production of iPSCs (induced pluripotent stem cells).

The post Cellevate, Fraunhofer IBMT and OLS consortium awarded EUR 1 million appeared first on NLS.

In 2023, there were an estimated 263 million malaria cases, and 597,000 malaria deaths, making it a prioritized field for many researchers around the world. In Umeå, Sweden, Professor Oliver Billker’s group is focusing on the basic biology of the parasite, with the goal to develop new drugs and vaccines and understand why some mosquito species transmit malaria while others do not.

The post World Malaria Day 2025: The ongoing challenge of putting an end to malaria appeared first on NLS.

Leon Wyszkowski, president of analytical services for clinical research, has received the Key to Gothenburg, on behalf of Thermo Fisher during a ceremony at the City Hall.

The post Thermo Fisher Scientific receives the Key to Gothenburg appeared first on NLS.

Hansa Biopharma has announced the appointment of Renée Aguiar-Lucander as Chief Executive Officer (CEO), effective immediately.

The post She is the new CEO of Hansa Biopharma appeared first on NLS.

The European Patent Office, EPO, has issued a decision to grant European patent for exidavnemab, a drug candidate being developed as a treatment for synucleinopathies such as Parkinson’s disease and Multiple System Atrophy (MSA).

The post BioArctic receives European patent for exidavnemab appeared first on NLS.